市場調査レポート

商品コード

1441199

神経リハビリテーション機器の世界市場規模、シェア、成長分析、製品別、治療領域別 - 産業予測2023～2030年

Global Neurorehabilitation Devices Market Size, Share, Growth Analysis, By Product(Neurorobotics, Brain-computer interface), By Therapy Area(Stroke, Multiple Sclerosis) - Industry Forecast 2023-2030

出版日: 2024年02月21日 | 発行: SkyQuest

| ページ情報: 英文 157 Pages | 納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 830,828円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 971,912円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,112,996円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界の神経リハビリテーション機器市場規模は、2022年に24億9,000万米ドルと評価され、2023年の28億9,000万米ドルから、予測期間中（2024～2031年）に15.9％のCAGRで、2031年までに94億米ドルに成長する見通しです。

この市場は、脳卒中、多発性硬化症、パーキンソン病、脳性麻痺など、多様な神経疾患に対する効果的なリハビリテーション介入に対する需要の高まりに対応することを目的としています。この市場の成長を促進する主な要因は、高齢化やライフスタイルの変化などの要因による神経疾患の有病率の世界の上昇です。その結果、これらの症状の回復と管理を支援する革新的なソリューションに対するニーズが高まっています。神経リハビリテーション機器は、患者が自立を取り戻し、機能的能力を向上させることを目標とした個別化治療を提供します。人工知能、仮想現実、ロボット工学などの技術的進歩がもたらす機会にもかかわらず、神経リハビリテーション機器市場は課題に遭遇しています。これには、機器の有効性と使いやすさを高めるための継続的な研究開発の必要性が含まれます。このような技術を臨床に取り入れるには、広範な調査、臨床試験、規制当局の承認が必要です。とはいえ、世界の神経リハビリテーション機器市場は、神経疾患を持つ人々のリハビリテーションのニーズを満たす上で重要な役割を果たしています。有病率の増加などの要因が市場成長の促進力となる一方で、高コストや限定的な償還政策などの課題も存在します。しかし、現在進行中の研究開発は、新たな技術を統合し、神経リハビリテーションサービスへのアクセスを拡大する機会を提供しています。結局のところ、神経リハビリテーション機器市場は、患者の生活を改善し、神経リハビリテーション療法を進歩させる上で大きな可能性を秘めています。

技術分析
価格分析
サプライチェーン分析
バリューチェーン分析
市場のエコシステム
IP分析
貿易分析
スタートアップ分析
原材料の分析
イノベーションマトリクス
パイプライン製品の分析
マクロ経済指標
主な投資の分析
主な成功要因
競合の程度

市場力学と見通し

市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
規制情勢
ポーターの分析
将来の混乱についての特別な考察

世界の神経リハビリテーション機器市場：製品別

市場概要
ニューロロボティクス
ブレインコンピューターインターフェース
ウェアラブルデバイス
非侵襲的刺激装置

世界の神経リハビリテーション機器市場：治療領域別

市場概要
脳卒中
多発性硬化症
パーキンソン病
脳性麻痺
その他

世界の神経リハビリテーション機器市場規模：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

主要5社の比較
主要企業の市場ポジショニング（2021年）
主な市場企業が採用した戦略
主要成功戦略
市場における最近の活動
主要企業の市場シェア（2021年）

主要企業プロファイル

Medtronic（US）
Abbott Laboratories（US）
Boston Scientific Corporation（US）
Stryker Corporation（US）
Smith & Nephew plc（UK）
Bioness Inc.（US）
Hocoma AG（Switzerland）
St. Jude Medical（US）
Ekso Bionics Holdings, Inc.（US）
Bioxtreme Robotics Rehabilitation（Italy）
ReWalk Robotics Ltd.（Israel）
Neurostyle Pte. Ltd.（Singapore）
Kinova Robotics（Canada）
Neuro Rehab VR（US）
Tyromotion GmbH（Austria）
Neofect（South Korea）
Enraf-Nonius（Netherlands）
Hobbs Rehabilitation（UK）
Motek Medical B.V.（Netherlands）
Biodex Medical Systems, Inc.（US）

Product Code: SQMIG35A2377

Global Neurorehabilitation Devices Market size was valued at USD 2.49 Billion in 2022 and is poised to grow from USD 2.89 Billion in 2023 to USD 9.40 Billion by 2031, at a CAGR of 15.9% during the forecast period (2024-2031).

The market aims to meet the rising demand for effective rehabilitation interventions for diverse neurological conditions including stroke, multiple sclerosis, Parkinson's disease, and cerebral palsy, among others. A key factor driving the growth of this market is the escalating prevalence of neurological disorders worldwide, attributed to factors like aging populations and lifestyle changes. Consequently, there is a significant need for innovative solutions aiding in the recovery and management of these conditions. Neurorehabilitation devices provide personalized therapies targeted at helping patients regain independence and enhance functional abilities. Despite opportunities presented by technological advancements like artificial intelligence, virtual reality, and robotics, the neurorehabilitation devices market encounters challenges. These include the necessity for continuous research and development to enhance device effectiveness and usability. Integrating such technologies into clinical practice requires extensive research, clinical trials, and regulatory approvals. Nevertheless, the global neurorehabilitation devices market plays a vital role in meeting the rehabilitation needs of individuals with neurological conditions. While factors such as increasing prevalence drive market growth, challenges such as high costs and limited reimbursement policies exist. Yet, ongoing research and development efforts present opportunities to integrate emerging technologies and broaden access to neurorehabilitation services. Ultimately, the neurorehabilitation devices market holds significant promise in improving patient lives and advancing neurorehabilitation therapies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Neurorehabilitation Devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Neurorehabilitation Devices Market Segmental Analysis

The global neurorehabilitation devices market is segmented on the basis of product, therapy area, and region. In terms of product, the market is segmented into Neurorobotics, Brain-computer interface, Wearable devices, and Non-invasive Stimulators. By Therapy Area, the market is segmented into Refrigerant, Industrial Solvent, Silicone Polymers, Laboratory Chemicals, Chemical Intermediates, Methylating & Chlorinating Agent, Propellant & Blowing Agent, Catalyst Carrier, Herbicide, Local Anesthetic, Adhesives and Sealants, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Neurorehabilitation Devices Market

A key factor propelling the neurorehabilitation devices market is the ongoing progress in technology. Recent years have witnessed notable advancements in fields like robotics, virtual reality, wearable sensors, and brain-computer interfaces. These advancements have facilitated the creation of more refined and efficient neurorehabilitation devices, offering tailored therapies and individualized rehabilitation solutions for patients. For instance, robotic exoskeletons such as Ekso Bionics' EksoGT and ReWalk Robotics' ReWalk system are developed to aid individuals with mobility limitations in walking and enhancing their motor abilities.

The increasing occurrence of neurological conditions like stroke, multiple sclerosis, and Parkinson's disease is fuelling the need for neurorehabilitation devices. As per the World Health Organization, the global impact of neurological disorders is on the rise, primarily influenced by factors such as aging demographics and shifts in lifestyle patterns. Consequently, there's an escalating demand for efficient rehabilitation strategies aimed at assisting individuals in restoring functionality and enhancing their overall well-being.

Restraints in the Global Neurorehabilitation Devices Market

One of the main restraints in the neurorehabilitation devices market is the high cost associated with these devices. Advanced technologies, such as robotics and brain-computer interfaces, can make the devices expensive. Additionally, the specialized expertise required for their effective utilization can increase the overall cost of treatment. This cost factor can limit the accessibility of neurorehabilitation devices, particularly in regions with limited healthcare resources or inadequate insurance coverage.

Another challenge involves the restricted reimbursement policies concerning neurorehabilitation devices and therapies within certain healthcare systems. Reimbursement policies differ among countries, and in certain instances, the coverage for neurorehabilitation devices might be insufficient. This limited reimbursement scenario can present obstacles for both patients and healthcare providers, impeding the broad adoption of these devices and potentially restricting access to innovative neurorehabilitation treatments.

Market Trends of the Global Neurorehabilitation Devices Market

Tele-rehabilitation emerges as a prominent trend in the neurorehabilitation devices market, characterized by the uptake of remote rehabilitation solutions. Through tele-rehabilitation, patients can remotely access rehabilitation services via technology, connecting with healthcare professionals and participating in therapy sessions from the comfort of their homes. This trend has surged notably amid the COVID-19 pandemic, addressing constraints faced by in-person rehabilitation services. Tele-rehabilitation presents benefits such as convenience, enhanced accessibility, and opportunities for ongoing monitoring and personalized care

Customized and Dynamic Innovations: The neurorehabilitation market is experiencing a shift towards the creation of customized and adaptable technologies. These innovations strive to customize rehabilitation approaches based on the unique requirements, abilities, and progress of individual patients. Progress in sensor technology, artificial intelligence, and data analysis facilitates the gathering and assessment of patient-specific data, enabling the implementation of more precise and efficient rehabilitation regimens. Customized and adaptable technologies present the opportunity for improved results and increased patient involvement.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Neurorehabilitation Devices Market by Product

Market Overview
Neurorobotics
Brain-computer interface
Wearable devices
and Non-invasive Stimulators

Global Neurorehabilitation Devices Market by Therapy Area

Market Overview
Stroke
Multiple Sclerosis
Parkinson's Disease
Cerebral Palsy
and Others

Global Neurorehabilitation Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Smith & Nephew plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioness Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hocoma AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
St. Jude Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ekso Bionics Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioxtreme Robotics Rehabilitation (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ReWalk Robotics Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neurostyle Pte. Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kinova Robotics (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neuro Rehab VR (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tyromotion GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neofect (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Enraf-Nonius (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hobbs Rehabilitation (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Motek Medical B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biodex Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments